Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) yesterday announced that the US Food and Drug Administration (FDA) had granted marketing approval following its Phase III clinical study of Fanapt™ (iloperidone). Tang Capital Partners has ended its proxy contest by withdrawing its nominations of director candidates for election to VNDA’s Board of Directors and its stockholder proposal to liquidate [...]
Archive for the ‘Tang Capital Partners’ Category
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) up on FDA approval; Greenbackd exits
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA), tagged Activist investment, Liquidating Value, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on May 8, 2009 | 3 Comments »
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Q1 results
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA), tagged Activist investment, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on April 30, 2009 | 5 Comments »
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has reported its results for the first quarter ended March 31, 2009. We’ve been following VNDA (see our post archive here) because it’s trading below its net cash value and Tang Capital Partners (TCP) has called for the company to “cease operations immediately, liquidate [VNDA]’s assets and distribute all remaining capital [...]
Tang Capital Partners files proxy statement for VNDA
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA), tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on April 8, 2009 | Leave a Comment »
Tang Capital Partners has filed a preliminary proxy statement for the Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 2009 Annual Meeting of Stockholders urging stockholders to support Tang Capital Partners’ slate of two director nominees, Kevin C. Tang and Andrew D. Levin, M.D., Ph.D. We’ve been following VNDA (see our post archive here) because it’s trading below its [...]
Vanda Pharmaceuticals Inc (NASDAQ:VNDA)
Posted in Activist Investors, Net Cash Stocks, Stocks, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA), tagged Activist investment, Liquidating Value, Net Cash Stock, Tang Capital Partners, Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on March 12, 2009 | 4 Comments »
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is trading below its net cash value and an investor, Tang Capital Partners (TCP), has called for the company to “cease operations immediately, liquidate [VNDA]‘s assets and distribute all remaining capital to the Stockholders.” At the company’s $0.78 closing price yesterday, VNDA has a market capitalization of $20.8M. We estimate the [...]

